Abbott Reports First Commercial Use Of Volt Pulsed System In Canadian Atrial Fibrillation Care

Abbott Laboratories announced that its Volt pulsed field ablation system was used for the first time in Canada at Montreal's McGill University Health Centre to treat atrial-fibrillation patients. The milestone expands real-world adoption of Abbott's cardiac-care technology, but no financial impact, sales outlook, or patient-volume data were disclosed.